Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06118502 · ClinicalTrials.gov registry record · NA
A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse
A NA study of Cigarette Smoking and Smoking Behaviors, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- NA
- Development phase
- 544
- Enrollment target
- 1
- Study location
NCT06118502: Recruiting NA study of Cigarette Smoking and Smoking Behaviors, sponsored by Medical University of South Carolina.
NCT06118502 is a NA study of Cigarette Smoking and Smoking Behaviors that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 544 participants, above the 164-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (232% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06118502, a NA study of Cigarette Smoking and Smoking Behaviors, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- NA
- Development phase
- 544 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a research study to find out if treatment decision making can be improved for smokers who find it difficult to quit with medications. Everyone who participates in this study will receive free product, either nicotine replacement therapies (patches and lozenges), varenicline, or a harm reduction product (e-cigarette) for a full 12 weeks. Most participants will receive some combination of these treatments, depending on individual response to each. All visits and study assessments will be entirely remote. All treatments will be provided free of charge for the first 12 weeks. After that, the study team will contact the participants 6 months after the first study phone call to complete another survey. The study lasts six months and will involve 8 surveys.
Primary Outcome
7-day point prevalence abstinence at Week 8 among non-responders at Week 4
Conditions Studied
Interventions
- BEHAVIORAL Switching to a different medication
- BEHAVIORAL Continued use of the same medication
- BEHAVIORAL Switching to a harm reduction tobacco product
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 544 participants |
| Start Date | 2024-03-25 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT06118502 shows while recruiting
NCT06118502 is an interventional study that assigns participants to a tested intervention. The registered 544 participants enrollment target is mid-sized for trials with a published cap, above the 164-participant average among 45 other Cigarette Smoking trials with a reported enrollment target (232% higher).
The record links to 3 conditions, with Cigarette Smoking appearing as the primary indexed condition, and to 3 interventions - of which Switching to a different medication is the first listed.
NCT06118502 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT06118502 about?
NCT06118502 is a clinical study titled "A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse". This is a research study to find out if treatment decision making can be improved for smokers who find it difficult to quit with medications. Everyone who participates in this study will receive free product, either nicotine replacement therapies (patches and lozenges), varenicline, or a harm reduct...
What is the current status of trial NCT06118502?
This trial is currently recruiting. It is a NA study. The enrollment target is 544 participants. The study started on 2024-03-25. Estimated completion is 2028-03-31.
What conditions does trial NCT06118502 study?
This clinical trial studies the following conditions: Cigarette Smoking, Smoking Behaviors, Treatment.
What interventions are being tested in trial NCT06118502?
The interventions under investigation include: Switching to a different medication (BEHAVIORAL), Continued use of the same medication (BEHAVIORAL), Switching to a harm reduction tobacco product (BEHAVIORAL).
Who is sponsoring clinical trial NCT06118502?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06118502 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cigarette Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06118502's enrollment target sits among peer trials
544 3rd of 45 higher than 43 of 45 other Cigarette Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cigarette Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effects of Tax Proposals and Cigarette Availability on Tobacco Purchasing
RECRUITING · NA
-
Menthol, Inflammation, and Nicotine Transition Study
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Development of a Mobile Health Intervention for Electronic Cigarette Use Among Young Adults
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
-
Effects of a Low Nicotine Standard and Tobacco Prices on Illegal Cigarette Purchasing
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03127761 · 544 participants
Assessment of Allogeneic Hematopoietic Cell Transplantation in Medicare Beneficiaries With Multiple Myeloma
- NCT04378790 · 544 participants · Phase 3
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching
- NCT06170437 · 544 participants · NA
Smoke-free Home Study in Subsidized Housing
- NCT06785064 · 544 participants · NA
Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI